These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1149 related items for PubMed ID: 17440955

  • 1. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
    Meijnen P, Oldenburg HS, Loo CE, Nieweg OE, Peterse JL, Rutgers EJ.
    Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
    [Abstract] [Full Text] [Related]

  • 2. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
    Goyal A, Douglas-Jones A, Monypenny I, Sweetland H, Stevens G, Mansel RE.
    Breast Cancer Res Treat; 2006 Aug; 98(3):311-4. PubMed ID: 16552627
    [Abstract] [Full Text] [Related]

  • 3. The role of sentinel node biopsy in ductal carcinoma in situ of the breast.
    Polom K, Murawa D, Wasiewicz J, Nowakowski W, Murawa P.
    Eur J Surg Oncol; 2009 Jan; 35(1):43-7. PubMed ID: 18723312
    [Abstract] [Full Text] [Related]

  • 4. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma.
    Sakr R, Antoine M, Barranger E, Dubernard G, Salem C, Daraï E, Uzan S.
    Breast J; 2008 Jan; 14(1):55-60. PubMed ID: 18186866
    [Abstract] [Full Text] [Related]

  • 5. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.
    Han JS, Molberg KH, Sarode V.
    Breast J; 2011 Jan; 17(3):223-9. PubMed ID: 21545433
    [Abstract] [Full Text] [Related]

  • 6. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
    Mittendorf EA, Arciero CA, Gutchell V, Hooke J, Shriver CD.
    Curr Surg; 2005 Jan; 62(2):253-7. PubMed ID: 15796952
    [Abstract] [Full Text] [Related]

  • 7. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH, Sweeney KJ, Wilson ME, Goldberg JI, Buchanan CL, Tan LK, Liberman L, Turner RR, Lagios MD, Cody Iii HS, Giuliano AE, Silverstein MJ, Van Zee KJ.
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
    Tunon-de-Lara C, Giard S, Buttarelli M, Blanchot J, Classe JM, Baron M, Monnier B, Houvenaeghel G.
    Breast J; 2008 Oct; 14(2):135-40. PubMed ID: 18315691
    [Abstract] [Full Text] [Related]

  • 10. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.
    Huo L, Sneige N, Hunt KK, Albarracin CT, Lopez A, Resetkova E.
    Cancer; 2006 Oct 15; 107(8):1760-8. PubMed ID: 16977650
    [Abstract] [Full Text] [Related]

  • 11. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ.
    Maffuz A, Barroso-Bravo S, Nájera I, Zarco G, Alvarado-Cabrero I, Rodríguez-Cuevas SA.
    J Exp Clin Cancer Res; 2006 Jun 15; 25(2):223-7. PubMed ID: 16918134
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ.
    Kurniawan ED, Rose A, Mou A, Buchanan M, Collins JP, Wong MH, Miller JA, Mann GB.
    Arch Surg; 2010 Nov 15; 145(11):1098-104. PubMed ID: 21079099
    [Abstract] [Full Text] [Related]

  • 15. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
    Sakr R, Barranger E, Antoine M, Prugnolle H, Daraï E, Uzan S.
    J Surg Oncol; 2006 Oct 01; 94(5):426-30. PubMed ID: 16967457
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
    Joseph KA, El-Tamer M, Komenaka I, Troxel A, Ditkoff BA, Schnabel F.
    Arch Surg; 2004 Jun 01; 139(6):648-51. PubMed ID: 15197092
    [Abstract] [Full Text] [Related]

  • 18. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
    Barth A, Craig PH, Silverstein MJ.
    Cancer; 1997 May 15; 79(10):1918-22. PubMed ID: 9149018
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
    Kim J, Han W, Lee JW, You JM, Shin HC, Ahn SK, Moon HG, Cho N, Moon WK, Park IA, Noh DY.
    Breast; 2012 Oct 15; 21(5):641-5. PubMed ID: 22749854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.